pifithrin has been researched along with Kidney Failure, Chronic in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, H | 1 |
| Bolati, D | 1 |
| Adijiang, A | 1 |
| Enomoto, A | 1 |
| Nishijima, F | 1 |
| Dateki, M | 1 |
| Niwa, T | 1 |
1 other study available for pifithrin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate.
Topics: Acetylcysteine; Animals; Benzothiazoles; Cell Line; Cell Proliferation; Cellular Senescence; Fibrosi | 2010 |